Class of 2022
Scientific Areas of Interest: Biomarkers, Cancer Immunology, Immunotherapy, Melanoma
For establishing groundbreaking and novel immunology-based treatment options for patients with multiple cancer types, conducting pivotal investigations involving the characterization of human antitumor immune responses, and for developing predictive biomarkers and neoadjuvant applications for immune checkpoint blockade.